de Jong, Y. P. and Dorner, M. and Balazs, A. B. and Robbins, J. B. and Labitt, R. N. and Donovan, B. M. and Krishnan, A. and Charlton, M. and Chiriboga, L. and Burton, D. R. and Rice, C. M. and Baltimore, D. and Law, M. and Ploss, A. (2013) The Effects of Broadly Neutralizing Antibodies in Experimental HCV Infection. Journal of Hepatology, 58 . S466-S467. ISSN 0168-8278. https://resolver.caltech.edu/CaltechAUTHORS:20130916-154115267
Full text is not posted in this repository. Consult Related URLs below.
Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:20130916-154115267
Abstract
Hepatitis C virus (HCV) infection is the leading indication for liver transplantation in the US. The graft is universally infected after transplantation, and this typically results in accelerated fibrosis progression. Current HCV therapies have poor efficacy and tolerability in the challenging pre- and posttransplant populations. Alternative pre- and post-transplantation measures are needed to prevent graft infection. One potential strategy to prevent such infection is the administration of potent broadly neutralizing antibodies (bnAbs).
| Item Type: | Article | ||||||
|---|---|---|---|---|---|---|---|
| Related URLs: |
| ||||||
| ORCID: |
| ||||||
| Additional Information: | © 2013 European Association for the Study of the Liver. | ||||||
| Record Number: | CaltechAUTHORS:20130916-154115267 | ||||||
| Persistent URL: | https://resolver.caltech.edu/CaltechAUTHORS:20130916-154115267 | ||||||
| Usage Policy: | No commercial reproduction, distribution, display or performance rights in this work are provided. | ||||||
| ID Code: | 41350 | ||||||
| Collection: | CaltechAUTHORS | ||||||
| Deposited By: | Tony Diaz | ||||||
| Deposited On: | 17 Sep 2013 20:00 | ||||||
| Last Modified: | 19 Nov 2020 20:33 |
Repository Staff Only: item control page
